Role of PD-1/PD-L1 signaling axis in oncogenesis and its targeting by bioactive natural compounds for cancer immunotherapy.

Autor: Godiyal Y; Department of Pharmacognosy and Phytochemistry, School of Pharmaceutical Sciences, Delhi Pharmaceutical Sciences and Research University, New Delhi, 110017, India., Maheshwari D; Department of Pharmacognosy and Phytochemistry, School of Pharmaceutical Sciences, Delhi Pharmaceutical Sciences and Research University, New Delhi, 110017, India., Taniguchi H; Department of Experimental Embryology, Institute of Genetics and Animal Biotechnology of the Polish Academy of Sciences, Jastrzebiec, 05-552, Magdalenka, Poland.; African Genome Center, Mohammed VI Polytechnic University, Hay Moulay Rachid, 43150, Ben Guerir, Morocco., Zinzuwadia SS; Department of Pharmacology, College of Osteopathic Medicine, Lake Erie College of Osteopathic Medicine, Bradenton, FL, 34211, USA., Morera-Díaz Y; Clinical Investigation and Biomedical Research Directions, Center for Genetic Engineering and Biotechnology, 11600, Havana, Cuba., Tewari D; Department of Pharmacognosy and Phytochemistry, School of Pharmaceutical Sciences, Delhi Pharmaceutical Sciences and Research University, New Delhi, 110017, India. devesh.tewari@dpsru.edu.in., Bishayee A; Department of Pharmacology, College of Osteopathic Medicine, Lake Erie College of Osteopathic Medicine, Bradenton, FL, 34211, USA. abishayee@lecom.edu.

Publikováno v: Military Medical Research [Mil Med Res] 2024 Dec 18; Vol. 11 (1), pp. 82. Date of Electronic Publication: 2024 Dec 18.

BioHabana 2022: Preventive and Immunotherapeutic Strategies Against COVID-19 and Cancer in Cuba.

Autor: Bello-Rivero I; Clinical Investigation and Biomedical Research Directions, Center for Genetic Engineering and Biotechnology (CIGB), Havana, Cuba., Crombet-Ramos T; Clinical Trial Directions, Center for Molecular Immunology (CIM), Havana, Cuba., Mesa-Pardillo C; Clinical Trial Directions, Center for Molecular Immunology (CIM), Havana, Cuba., Morera-Díaz Y; Clinical Investigation and Biomedical Research Directions, Center for Genetic Engineering and Biotechnology (CIGB), Havana, Cuba., Mazorra-Herrera Z; Clinical Trial Directions, Center for Molecular Immunology (CIM), Havana, Cuba., Garcia-Rivera D; Clinical Trial Direction, Vaccine Finlay Institute (IFV), Havana, Cuba., Nodarse-Cuní H; Clinical Investigation and Biomedical Research Directions, Center for Genetic Engineering and Biotechnology (CIGB), Havana, Cuba., Hernández-Bernal F; Clinical Investigation and Biomedical Research Directions, Center for Genetic Engineering and Biotechnology (CIGB), Havana, Cuba., Muzio-Gonzalez V; Clinical Investigation and Biomedical Research Directions, Center for Genetic Engineering and Biotechnology (CIGB), Havana, Cuba., Aguilera-Barreto A; Clinical Investigation and Biomedical Research Directions, Center for Genetic Engineering and Biotechnology (CIGB), Havana, Cuba., Vazquez-Blomquist D; Clinical Investigation and Biomedical Research Directions, Center for Genetic Engineering and Biotechnology (CIGB), Havana, Cuba., Domínguez-Horta MDC; Clinical Investigation and Biomedical Research Directions, Center for Genetic Engineering and Biotechnology (CIGB), Havana, Cuba., Guillen-Nieto G; Clinical Investigation and Biomedical Research Directions, Center for Genetic Engineering and Biotechnology (CIGB), Havana, Cuba.

Publikováno v: Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research [J Interferon Cytokine Res] 2023 Dec; Vol. 43 (12), pp. 571-580. Date of Electronic Publication: 2023 Dec 04.

Personalized nanovaccines for treating solid cancer metastases.

Autor: Feng, Tang^1,2 (AUTHOR), Hu, Jia^1,3 (AUTHOR), Wen, Jirui⁴ (AUTHOR), Qian, Zhiyong⁵ (AUTHOR), Che, Guowei³ (AUTHOR), Zhou, Qinghua³ (AUTHOR), Zhu, Lingling^1,3 (AUTHOR) zhulingling8262023@126.com

Publikováno v: Journal of Hematology & Oncology. 11/28/2024, Vol. 17 Issue 1, p1-50. 50p.

Specific humoral response in cancer patients treated with a VEGF-specific active immunotherapy procedure within a compassionate use program.

Autor: Sánchez Ramírez J; Department of Pharmaceuticals, Center of Genetic Engineering and Biotechnology (CIGB), Playa, 10600, Havana, Cuba. javier.sanchez@cigb.edu.cu., Morera Díaz Y; Department of Pharmaceuticals, Center of Genetic Engineering and Biotechnology (CIGB), Playa, 10600, Havana, Cuba., Bequet-Romero M; Department of Pharmaceuticals, Center of Genetic Engineering and Biotechnology (CIGB), Playa, 10600, Havana, Cuba., Hernández-Bernal F; Department of Clinical Research, CIGB, Playa, 10600, Havana, Cuba., Martín Bauta Y; Department of Clinical Research, CIGB, Playa, 10600, Havana, Cuba., Selman-Housein Bernal KH; Center of Medical and Surgical Research (CIMEQ), Playa, 12100, Havana, Cuba., de la Torre Santos AV; 'Celestino Hernández' Hospital, 50100, Santa Clara, Villa Clara, Cuba., Pérez de la Iglesia M; Development Unit, CIGB, Playa, 10600, Havana, Cuba., Trimiño Lorenzo L; Development Unit, CIGB, Playa, 10600, Havana, Cuba., Ayala Avila M; Department of Pharmaceuticals, Center of Genetic Engineering and Biotechnology (CIGB), Playa, 10600, Havana, Cuba.

Publikováno v: BMC immunology [BMC Immunol] 2020 Mar 14; Vol. 21 (1), pp. 12. Date of Electronic Publication: 2020 Mar 14.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.